Latest News about ABT
Recent news which mentions ABT
From Motley Fool
7 Long-Term Stocks to Buy Now and Hold Forever
March 03, 2022
From InvestorPlace
Consumer Spending, E-Commerce, and the Business of Lodging
March 02, 2022
From Motley Fool
From Benzinga
2 Fantastic Dividend Stocks for Retirees
March 02, 2022
From Motley Fool
Up 700%, DexCom Stock Still Has Tons of Room To Run
February 27, 2022
From Motley Fool
From Motley Fool
3 Pharma Stocks That Retired Investors Should Love
February 26, 2022
From Motley Fool
Got $5,000? These 2 Dividend Kings Are On Sale
February 24, 2022
From Motley Fool
Want to Get Richer? 5 Best Stocks to Buy Now and Hold Forever
February 22, 2022
From Motley Fool
Is Now the Time to Buy This Blue-Chip Healthcare Stock?
February 21, 2022
Tickers
ABT
From Motley Fool
Bull vs. Bear: DexCom Stock
February 20, 2022
From Motley Fool
AbbVie Is a Better Stock Than You Might Think -- Here's Why
February 17, 2022
From Motley Fool
Why This Healthcare Giant Expects Decreased Covid Profits in 2022
February 11, 2022
Tickers
ABT
From Motley Fool
3 Top Healthcare Stocks to Buy for February
February 08, 2022
From Motley Fool
AbbVie Wins Yet Another Approval for This Drug
February 07, 2022
From Motley Fool
Should Investors Sell the Rumor With ShockWave Medical?
February 04, 2022
From Motley Fool
6 Stocks That Could Soar If New Coronavirus Variants Emerge
February 04, 2022
From Motley Fool
Half The American Population May Suffer From Chronic Illnesses By 2025, According To This Report
February 03, 2022
From Benzinga
Microsoft's Gaming Ambitions and COVID-19 Stocks
February 01, 2022
From Motley Fool
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
What 5 Analyst Ratings Have To Say About Abbott Laboratories
January 27, 2022
Tickers
ABT
From Benzinga
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
January 26, 2022
Tickers
ABT
From Motley Fool
Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook
January 26, 2022
Tickers
ABT
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.